141 related articles for article (PubMed ID: 33912514)
1. Radiation-induced haemorrhagic cystitis after prostate cancer radiotherapy: factors associated to hospitalization and treatment strategies.
Sanguedolce F; Sancho Pardo G; Mercadé Sanchez A; Balaña Lucena J; Pisano F; Cortez JC; Territo A; Huguet Perez J; Gaya Sopeña J; Esquina Lopez C; Breda A; Palou Redorta J
Prostate Int; 2021 Mar; 9(1):48-53. PubMed ID: 33912514
[TBL] [Abstract][Full Text] [Related]
2. Intravesical instillation with glycosaminoglycan replacement treatment in patients suffering radiation-induced haemorrhagic cystitis: When and which patients can benefit most from it?
Sanguedolce F; Meneghetti I; Bevilacqua G; Montaño B; Martínez C; Territo A; Balaña J; Palou J; Breda A
Urol Oncol; 2022 Jul; 40(7):344.e19-344.e25. PubMed ID: 35400568
[TBL] [Abstract][Full Text] [Related]
3. A population-based study of the use and outcome of radical radiotherapy for invasive bladder cancer.
Hayter CR; Paszat LF; Groome PA; Schulze K; Math M; Mackillop WJ
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1239-45. PubMed ID: 10613319
[TBL] [Abstract][Full Text] [Related]
4. Radical radiotherapy in older patients with muscle invasive bladder cancer.
Wujanto C; Tey J; Chia D; Ho F; Ooi KH; Wong AS; Soon YY; Lim K
J Geriatr Oncol; 2019 Mar; 10(2):292-297. PubMed ID: 30630748
[TBL] [Abstract][Full Text] [Related]
5. Outcome of a 980-nm diode laser coagulation in women with radiation-induced hemorrhagic cystitis: a single-center retrospective study.
Zhang N; Yao DW; Liu XJ; Sun Y; Song Q
Lasers Med Sci; 2021 Feb; 36(1):67-73. PubMed ID: 32304002
[TBL] [Abstract][Full Text] [Related]
6. [THE RISK AND MANAGEMENT OF RADIATION INDUCED CYSTITIS AFTER RADIOTHERAPY FOR PROSTATE CANCER].
Chiba K; Sugawara S; Kamada S; Inoue T; Nozumi K; Miyazaki K; Inoue A; Nagata M; Matsui T; Yamaguchi K
Nihon Hinyokika Gakkai Zasshi; 2017; 108(2):80-86. PubMed ID: 29669981
[TBL] [Abstract][Full Text] [Related]
7. A study of the morbidity, mortality and long-term survival following radical cystectomy and radical radiotherapy in the treatment of invasive bladder cancer in Yorkshire.
Chahal R; Sundaram SK; Iddenden R; Forman DF; Weston PM; Harrison SC
Eur Urol; 2003 Mar; 43(3):246-57. PubMed ID: 12600427
[TBL] [Abstract][Full Text] [Related]
8. Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial.
Denham JW; Joseph D; Lamb DS; Spry NA; Duchesne G; Matthews J; Atkinson C; Tai KH; Christie D; Kenny L; Turner S; Gogna NK; Diamond T; Delahunt B; Oldmeadow C; Attia J; Steigler A
Lancet Oncol; 2019 Feb; 20(2):267-281. PubMed ID: 30579763
[TBL] [Abstract][Full Text] [Related]
9. Cumulative incidence and predictive factors of radiation cystitis in patients with localized prostate cancer.
Afonso-João D; Pacheco-Figueiredo L; Antunes-Lopes T; Morgado LA; Azevedo V; Vendeira L; Silva J; Martins-Silva C
Actas Urol Esp (Engl Ed); 2018 May; 42(4):256-261. PubMed ID: 29169704
[TBL] [Abstract][Full Text] [Related]
10. Long-term experience of hyperbaric oxygen therapy for refractory radio- or chemotherapy-induced haemorrhagic cystitis.
Degener S; Pohle A; Strelow H; Mathers MJ; Zumbé J; Roth S; Brandt AS
BMC Urol; 2015 May; 15():38. PubMed ID: 25953493
[TBL] [Abstract][Full Text] [Related]
11. Correlation between urinary dose and delayed radiation cystitis after 78 Gy intensity-modulated radiotherapy for high-risk prostate cancer: A 10-year follow-up study of genitourinary toxicity in clinical practice.
Inokuchi H; Mizowaki T; Norihisa Y; Takayama K; Ikeda I; Nakamura K; Hiraoka M
Clin Transl Radiat Oncol; 2017 Oct; 6():31-36. PubMed ID: 29594221
[TBL] [Abstract][Full Text] [Related]
12. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
Heidenreich A; Ohlmann C; Ozgür E; Engelmann U
Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
[TBL] [Abstract][Full Text] [Related]
13. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
14. Cystoscopic application of PuraStat® in the treatment of radiation-induced haemorrhagic cystitis.
Darwazeh H; Hemsworth L; Smith L; Ilie PC
Ann R Coll Surg Engl; 2024 Feb; ():. PubMed ID: 38362741
[TBL] [Abstract][Full Text] [Related]
15. Late toxicity after post-prostatectomy intensity modulated radiation therapy: Evaluating normal-tissue sparing guidelines.
Akthar AS; Wong AC; Parekh AD; Hubert G; Son CH; Pelizzari CA; Liauw SL
Adv Radiat Oncol; 2018; 3(3):339-345. PubMed ID: 30202803
[TBL] [Abstract][Full Text] [Related]
16. Postoperative radiation therapy for patients at high-risk of recurrence after radical prostatectomy: does timing matter?
Hsu CC; Paciorek AT; Cooperberg MR; Roach M; Hsu IC; Carroll PR
BJU Int; 2015 Nov; 116(5):713-20. PubMed ID: 25600860
[TBL] [Abstract][Full Text] [Related]
17. Actinic cystitis: causes, treatment and experience of a single centre in the last five years.
Mangano MS; De Gobbi A; Ciaccia M; Lamon C; Beniamin F; Maccatrozzo L
Urologia; 2018 Feb; 85(1):25-28. PubMed ID: 29027183
[TBL] [Abstract][Full Text] [Related]
18. Long-term Outcomes After Bladder-preserving Tri-modality Therapy for Patients with Muscle-invasive Bladder Cancer: An Updated Analysis of the Massachusetts General Hospital Experience.
Giacalone NJ; Shipley WU; Clayman RH; Niemierko A; Drumm M; Heney NM; Michaelson MD; Lee RJ; Saylor PJ; Wszolek MF; Feldman AS; Dahl DM; Zietman AL; Efstathiou JA
Eur Urol; 2017 Jun; 71(6):952-960. PubMed ID: 28081860
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated helical tomotherapy (75 Gy at 2.5 Gy per fraction) for localized prostate cancer: long-term analysis of gastrointestinal and genitourinary toxicity.
Kong M; Hong SE; Chang SG
Onco Targets Ther; 2014; 7():553-66. PubMed ID: 24748805
[TBL] [Abstract][Full Text] [Related]
20. Bladder dose-volume parameters are associated with urinary incontinence after postoperative intensity modulated radiation therapy for prostate cancer.
Son CH; Melotek JM; Liao C; Hubert G; Pelizzari CA; Eggener SE; Liauw SL
Pract Radiat Oncol; 2016; 6(5):e179-e185. PubMed ID: 26961716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
